Neuropsychological Criteria for Mild Cognitive Impairment Improves Diagnostic Precision, Biomarker Associations, and Progression Rates

Journal of Alzheimer's Disease

Volumn 42, Issue 1, 2014, Pages 275-289

  Bondi, Mark W ^a,b   Edmonds, Emily C ^b   Jak, Amy J ^a,b   Clark, Lindsay R ^d   Delano Wood, Lisa ^a,b   McDonald, Carrie R ^b   Nation, Daniel A ^e   Libon, David J ^f   Au, Rhoda ^g   Galasko, Douglas ^a,c   Salmon, David P ^c  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^g FRAMINGHAM HEART STUDY   (United States)

Author keywords

Alzheimer's disease; Alzheimer's Disease Neuroimaging Initiative; biomarker; cluster analysis; dementia; mild cognitive impairment; neuropsychology; progression

Indexed keywords

APOLIPOPROTEIN E; BIOLOGICAL MARKER; MAPT PROTEIN, HUMAN; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; ALZHEIMER DISEASE NEUROIMAGING INITIATIVE CRITERIA; ARTICLE; BOSTON NAMING TEST; CEREBROSPINAL FLUID; CLUSTER ANALYSIS; CONTROLLED STUDY; DEMENTIA ASSESSMENT; DIAGNOSTIC ACCURACY; DISCRIMINANT ANALYSIS; DISEASE CLASSIFICATION; DISEASE COURSE; EXECUTIVE FUNCTION TEST; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; GENE FREQUENCY; HUMAN; LANGUAGE TEST; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; TRAIL MAKING TEST; WECHSLER MEMORY SCALE; COMPARATIVE STUDY; GENETICS; MIDDLE AGED; PHOSPHORYLATION; PSYCHOLOGY; SENSITIVITY AND SPECIFICITY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; APOLIPOPROTEINS E; BIOMARKERS; CLUSTER ANALYSIS; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PHOSPHORYLATION; SENSITIVITY AND SPECIFICITY; TAU PROTEINS;

EID: 84940901707     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-140276     Document Type: Article

References (56)

1. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
2. Flicker C, Ferris SH, Reisberg B (1991) Mild cognitive impairment in the elderly: Predictors of dementia. Neurology 41, 1006-1009.
3. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 56, 303-308.
4. Petersen RC, Morris JC (2005) Mild cognitive impairment as a clinical entity and treatment target. Arch Neurol 62, 1160-1163.
5. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Bäckman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC (2004) Mild cognitive impairment beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment. J Intern Med 256, 240-246.
6. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging -Alzheimer's Association workgroup. Alzheimers Dement 7, 263-269.
7. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH (2011) The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging and Alzheimer's Association workgroup. Alzheimers Dement 7, 270-279.
8. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging - Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 280-292.
9. Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeiffer E, Sano M, van Dyck CH, Thal LJ, Alzheimer's Disease Cooperative Study, Group (2005) Vitamin E and donepezil for the treatment of mild cognitive impairment. New Engl J Med 352, 2379-2388.
10. WechslerD(1987)Wechsler Memory Scale-Revised, The Psychological Corporation, New York.
11. Bondi MW, Monsch AU, Galasko D, Butters N, Salmon DP, Delis DC (1994) Preclinical cognitive markers of dementia of the Alzheimer type. Neuropsychology 8, 374-384.
12. Bondi MW, Salmon DP, Galasko D, Thomas RG, Thal J (1999) Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease. Psychol Aging 14, 295-303.
13. DeJager CA, Hogervorst E, Combrinck M, Budge MM(2003) Sensitivity and specificity of neuropsychological tests for mild cognitive impairment, vascular cognitive impairment and Alzheimer's disease. Psychol Med 33, 1039-1050.
14. Lange KL, Bondi MW, Salmon DP, Galasko D, Delis DC, Thomas RG, Thal LJ (2002) Decline in verbal memory during preclinical Alzheimer's disease: Examination of the effect of APOE genotype. J Int Neuropsychol Soc 8, 943-955.
15. Rabin LA, Paré N, Saykin AJ, Brown MJ, Wishart HA, Flashman LA, Santulli RB (2009) Differential memory test sensitivity for diagnosing amnestic mild cognitive impairment and predicting conversion to Alzheimer's disease. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 16, 57-76.
16. Tierney MC, Yao C, Kiss A, McDowell I (2005) Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years. Neurology 64, 1853-1859.
17. Kawas CH, Corrada MM, Brookmeyer R, Morrison A, Resnick SM, Zonderman AB, Arenberg D (2003) Visual memory predicts Alzheimer's disease more than a decade before diagnosis. Neurology 60, 1089-1093.
18. Anastasi A, Urbina S (1997) Psychological Testing, 7th edition. Prentice Hall, Upper Saddle River, NJ.
19. Ferman TJ, Smith GE, Kantarci K, Boeve BF, Pankratz VS, Dickson DW, Graff-Radford NR, Wszolek Z, Van Gerpen J, Uitti R, Pedraza O, Murray ME, Aakre J, Parisi J, Knopman DS, Petersen RC (2013) Nonamnestic mild cognitive impairment progesses to dementia with Lewy bodies. Neurology 81, 2032-2038.
20. Jak AJ, Urban S, McCauley A, Bangen KJ, Delano-Wood L, Corey-Bloom J, Bondi MW (2009) Profile of hippocampal volumes and stroke risk varies by neuropsychological definition of mild cognitive impairment. J Int Neuropsychol Soc 15, 890-897.
21. Loewenstein DA, Acevedo A, Small BJ, Agron J, Crocco E, Duara R (2009) Stability of different subtypes of mild cognitive impairment among the elderly over a 2- to 3- year follow-up period. Dement Geriatr Cogn Disord 27, 418-423.
22. Saxton J, Snitz BE, Lopez OL, Ives DG, Dunn LO, Fitzpatrick A, Carlson MC, Dekosky ST, Study GE M, Investigators (2009) Functional and cognitive criteria produce different rates of mild cognitive impairment and conversion to dementia. J Neurol Neurosurg Psychiatry 80, 737-743.
23. Dawes RM, Faust D, Meehl PE (1989) Clinical versus acturial judgment. Science 243, 1668-1674.
24. Bondi MW, Jak AJ, Delano-Wood L, Jacobson MW, Delis DC, Salmon DP (2008) Neuropsychological contributions to the early identification of Alzheimer's disease. Neuropsychol Rev 18, 73-90.
25. Jak AJ, Bondi MW, Delano-Wood L, Wierenga C, Corey-Bloom J, Salmon DP, Delis DC (2009) Quantification of five neuropsychological approaches to defining mild cognitive impairment. Am J Geriatr Psychiatry 17, 368-375.
26. Ward A, Arrighi HM, Michels S, Cedarbaum JM (2012) Mild cognitive impairment: Disparity of incidence and prevalence estimates. Alzheimers Dement 8, 14-21.
27. Delano-Wood L, Bondi MW, Sacco J, Abeles N, Jak AJ, Libon DJ, Bozoki A (2009) Heterogeneity in mild cognitive impairment: Differences in neuropsychological profile and associated white matter lesion pathology. J Int Neuropsychol Soc 15, 906-914.
28. Libon DJ, Xie SX, Eppig J, Wicas G, Lamar M, Lippa C, Bettcher BM, Price CC, Giovannetti T, Swenson R, Wambach DM (2010) The heterogeneity of mild cognitive impairment: A neuropsychological analysis. J Int Neuropsychol Soc 16, 84-93.
29. Libon DJ, Bondi MW, Price CC, Lamar M, Eppig J, Wambach DM, Nieves C, Delano-Wood L, Giovannetti T, Lippa C, Kabasakalian A, Cosentino S, Swenson R, Penney DL (2011) Verbal serial list learning in mild cognitive impairment: A profile analysis of interference, forgetting, and errors. J Int Neuropsychol Soc 17, 905-914.
30. Eppig J, Wambach D, Nieves C, Price CC, Lamar M, Delano-Wood L, Giovannetti T, Bettcher BM, Penney DL, Swenson R, Lippa C, Kabasakalian A, Bondi MW, Libon DJ (2012) Dysexecutive functioning in mild cognitive impairment: Derailment in temporal gradients. J Int Neuropsychol Soc 18, 20-28.
31. Clark LR, Delano-Wood L, Libon DJ, McDonald CR, Nation DA, Bangen KJ, Jak AJ, Au R, Salmon DP, Bondi MW(2013) Are empirically derived subtypes of mild cognitive impairment diagnoses consistent with conventional subtypes? J Int Neuropsychol Soc 19, 635-645.
32. Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A (1980) Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 7, 486-488.
33. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO (1983) Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatr Res 17, 37-49.
34. Pfeffer RI, Kurosaki TT, Harrah CH Jr, Chance JM, Filos S (1982) Measurement of functional activities of older adults in the community. J Gerontol 37, 323-329.
35. Kaufer DI, Cummings JL, Ketchel P, Smith V, MacMillan A, Shelley T, Lopez OL, DeKosky ST (2000) Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci 12, 233-239.
36. Ivnik RJ, Malec JF, Smith GE, Tangalos EG, Petersen RC, Kokmen E, Kurland LT (1992) Mayo's older Americans normative studies: AVLT norms for ages 56 to 94. Clin Neuropshchol 6, 49-82.
37. Shirk SD, Mitchell MB, Shaughnessy LW, Sherman JC, Locascio JJ, Weintraub S, Atri A (2011) A web-based normative calculator for the uniform data set (UDS) neuropsychological test battery. Alzheimers Res Ther 3, 32.
38. Weintraub S, Salmon D, Mercaldo N, Ferris S, Graff-Radford NR, Chui H, Cummings J, DeCarli C, Foster NL, Galasko D, Peskind E, Dietrich W, Beekly DL, Kukull WA, Morris JC (2009) The Alzheimer's Disease Centers' Uniform Data Set (UDS): The neuropsychologic test battery. Alzheimer Dis Assoc Disord 23, 91-101.
39. Heaton RK, Avitable N, Grant I, Matthews CG (1999) Further cross validation of regression-based neuropsychological norms with an update for the Boston Naming Test. J Clin Exp Neuropsychol 21, 562-582.
40. Heaton RK, Miller SW, Taylor MJ, Grant I (2004) Revised Comprehensive Norms for an Expanded Halstead-Reitan Battery: Demographically Adjusted Neuropsychological Norms for African-American and Caucasian Adults. Psychological Assessment Resources, Inc., Lutz, FL.
41. Palmer BW, Boone KB, Lesser IM, Wohl MA (1998) Base rates of "impaired" neuropsychological test performance among healthy older adults. Arch Clin Neuropsychol 13, 503-511.
42. Brooks BL, Iverson GL, White T (2007) Substantial risk of 'accidental MCI' in healthy older adults: Base rates of low memory scores in neuropsychological assessment. J Int Neuropsychol Soc 13, 490-500.
43. Wechsler D (1997) Wechsler Memory Scale-II I, The Psychological Corporation, New York.
44. Busse A, Hensel A, Guhne U, Angermeyer MC, Riedel-Heller SG (2006) Mild cognitive impairment: Long-term course of four clinical subtypes. Neurology 67, 2176-2185.
45. Taylor MJ, Heaton RK (2001) Sensitivity and specificity of WAIS-III/WMS-III demographically corrected factor scores in neuropsychological assessment. J Int Neuropsychol Soc 7, 867-874.
46. Jorm AF, Butterworth P, Anstey KJ, Christensen H, Easteal S, Maller J, Mather KA, Turakulov RI, Wen W, Sachdev P (2004) Memory complaints in a community sample aged 60-64 years: Associations with cognitive functioning, psychiatric symptoms, medical conditions, APOE genotype, hippocampus and amygdala volumes, and white-matter hyperintensities. Psychol Med 34, 1495-1506.
47. Kliegel MK, Zimprich D, Eschen A (2005) What do subjective cognitive complaints in persons with aging-associated cognitive decline reflect? Int Psychgeriatr 17, 499-512.
48. Reid LM, MacLullich AM (2006) Subjective memory complaints and cognitive impairment in older people. Dement Geriatr Cogn Disord 22, 471-485.
49. Lineweaver TT, Bondi MW, Galasko D, Salmon DP (2014) Effect of knowledge of APOE genotype on subjective and objective memory performance in healthy older adults. Am J Psychiatry 171, 201-208.
50. Brooks BL, Iverson GL, Holdnack JA, Feldman HH (2008) Potential for misclassification of mild cognitive impairment: A study of memory scores on theWechsler Memory Scale-III in healthy older adults. J Int Neuropsychol Soc 14, 463-478.
51. Jack CR Jr, Knopman DS, Weigand SD, Wiste HJ, Vemuri P, Lowe V, Kantarci K, Gunter JL, Senjem ML, Ivnik RJ, Roberts RO, Rocca WA, Boeve BF, Petersen RC(2012)Anoperational approach to National Institute on Aging-Alzheimer's Association criteria for preclinial Alzheimer disease. Ann Neurol 71, 765-775.
52. Vos SJ, Xiong C, Visser PJ, Jasielec MS, Hassenstab J, Grant EA, Cairns NJ, Morris JC, Holtzman DM, Fagan AM (2013) Preclinical Alzheimer's disease and its outcome: A longitudinal cohort study. Lancet Neurol 12, 957-965.
53. Salmon DP, Bondi MW (2009) Neuropsychological assessment of dementia. Annu Rev Psychol 60, 257-282.
54. Smith GE, Bondi MW (2013) Mild Cognitive Impairment and Dementia: Definitions, Diagnosis, and Treatment. American Academy of Clinical Neuropsychology Oxford Workshop, Oxford University Press, USA.
55. Libon DJ, Drabick DA G, Giovannetti T, Price CC, Bondi MW, Eppig J, Nieves C, Wicas G, Lamar M, Delano-Wood L, Nation DA, Brennan L, Au R, Swenson R (2014) Neuropsychological syndromes associated with Alzheimer's/vascular spectrum dementia. J Alzheimers Dis [Epub ahead of print].
56. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, Petersen RC, Schneider JA, Tzourio C, Arnett DK, Bennett DA, Chui HC, Higashida RT, Lindquist R, Nilsson PM, Roman GC, Sellke FW, Seshadri S, American Heart Association Stroke Council, Council on Epidemiology, Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology, Intervention, Council on Cardiovascular Surgery, Anesthesia (2011) Vascular contributions to cognitive impairment and dementia: A statement for healthcare professionals from the American Heart Association/ American Stroke Association. Stroke 42, 2672-2713.